The Food and Drug Administration (FDA) will not be issuing new contracts to the consulting firm McKinsey and Co. amid an investigation into potential conflicts of interest, a top official has confirmed.
The U.S. House Oversight Committee is currently investigating McKinsey over allegations that it was working for the U.S. government on issues relating to the opioid epidemic while at the same time working for opioid companies, including Purdue Pharma.
During a Senate hearing on Tuesday, a top FDA official was questioned by Senator Maggie Hassan (D-N.H.) as to whether or not the federal agency would suspend current or future contracts with the management consulting firm.
…